A detailed history of Ubs Group Ag transactions in Beyond Air, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 189 shares of XAIR stock, worth $107. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189
Previous 25,783 99.27%
Holding current value
$107
Previous $44,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.54 - $1.67 $13,820 - $42,741
-25,594 Reduced 99.27%
189 $0
Q1 2024

May 13, 2024

BUY
$1.3 - $2.15 $9,551 - $15,796
7,347 Added 39.85%
25,783 $44,000
Q4 2023

Feb 09, 2024

BUY
$1.4 - $2.46 $3,388 - $5,953
2,420 Added 15.11%
18,436 $36,000
Q3 2023

Nov 09, 2023

SELL
$2.31 - $4.18 $13,314 - $24,093
-5,764 Reduced 26.46%
16,016 $36,000
Q2 2023

Aug 11, 2023

BUY
$4.26 - $6.92 $74,038 - $120,269
17,380 Added 395.0%
21,780 $92,000
Q1 2023

May 12, 2023

BUY
$5.65 - $7.56 $24,860 - $33,264
4,400 New
4,400 $29,000
Q2 2022

Aug 10, 2022

SELL
$4.96 - $7.83 $10,237 - $16,161
-2,064 Reduced 6.37%
30,336 $203,000
Q1 2022

May 16, 2022

BUY
$6.33 - $9.53 $25,585 - $38,520
4,042 Added 14.25%
32,400 $216,000
Q4 2021

Feb 14, 2022

BUY
$8.44 - $15.61 $161,085 - $297,932
19,086 Added 205.85%
28,358 $268,000
Q3 2021

Nov 15, 2021

SELL
$5.9 - $12.54 $15,316 - $32,553
-2,596 Reduced 21.87%
9,272 $103,000
Q2 2021

Aug 13, 2021

BUY
$4.72 - $7.15 $14,197 - $21,507
3,008 Added 33.95%
11,868 $77,000
Q1 2021

May 12, 2021

BUY
$5.13 - $7.24 $10,280 - $14,508
2,004 Added 29.23%
8,860 $49,000
Q4 2020

Feb 11, 2021

BUY
$5.18 - $6.03 $19,072 - $22,202
3,682 Added 116.01%
6,856 $36,000
Q3 2020

Nov 12, 2020

SELL
$4.86 - $7.07 $5,030 - $7,317
-1,035 Reduced 24.59%
3,174 $16,000
Q2 2020

Jul 31, 2020

SELL
$6.44 - $9.45 $35,040 - $51,417
-5,441 Reduced 56.38%
4,209 $31,000
Q1 2020

May 01, 2020

BUY
$3.94 - $10.93 $38,021 - $105,474
9,650 New
9,650 $77,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $17M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.